GNUBIO
GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which provides a scalable desktop sequencing system that allows interrogation of single genes, gene panels, and whole genomes. Using a proprietary DNA sequencing system, the GnuBIO’s platform encompasses all the steps required for DNA sequencing into a single platform including target selection and enrichment, DNA amplification, DNA sequencing and analysis. GnuBIO’s cutting-edge platform provides a single user interface, and a single step process, which rapidly produces results to hours versus days.
GNUBIO
Industry:
Biotechnology Genetics Health Care Medical Device
Founded:
2009-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.gnubio.com
Total Employee:
11+
Status:
Active
Contact:
617 446 6744
Total Funding:
22.5 M USD
Technology used in webpage:
SSL By Default WordPress IPv6 Google Maps Contact Form 7 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Tal Raz VP, Molecular Biology @ GnuBIO
VP, Molecular Biology
2010-12-01
Founder
Official Site Inspections
http://www.gnubio.com
- Host name: 172.67.195.121
- IP address: 172.67.195.121
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GnuBIO"
GnuBIO - Crunchbase Company Profile & Funding
GnuBIO is a developer of scalable DNA sequencing technology for both the Diagnostic and Applied markets. The GnuBIO technology is an emulsion-based microfluidic technology, which …See details»
GnuBIO | About GnuBIO
Sepehr leads the engineering efforts at GnuBIO, Inc and is responsible for overall product development and commercialization strategy. Prior to joining GnuBIO, Sepehr was Director of …See details»
Cutting-Edge DNA Sequencing with GnuBIO's …
GnuBIO provides the only fully-integrated DNA sequencing platform designed to meet the workflows of both research and clinical laboratories. Utilizing emulsion microfluidics, GnuBIO has been able to create a scalable DNA sequencing …See details»
GnuBIO, Inc - LinkedIn
GnuBIO, Inc | 2,354 followers on LinkedIn. GnuBIO Inc is a genomics company based in Cambridge, MA. We are pioneers in the field of DNA sequencing technology for the diagnostic …See details»
GnuBIO Company Profile 2024: Valuation, Investors, Acquisition
GnuBIO General Information Description. Manufacturer of DNA sequencing technology designed to meet the workflows of both research and clinical laboratories. The company utilizes …See details»
GnuBIO - VentureRadar
GnuBIO (www.gnubio.com) is a privately-held company developing next-generation desktop DNA sequencing technology that will compartmentalize the entire DNA sequencing process, …See details»
GnuBIO - Tech Stack, Apps, Patents & Trademarks - Crunchbase
GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.See details»
GnuBIO Inc. Company Profile | Hercules, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GnuBIO Inc. of Hercules, CA. Get the latest business insights from Dun & Bradstreet.See details»
Bio-Rad Acquires GnuBIO and DNA Sequencing Technology
Hercules, CA April 10, 2014 Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global manufacturer and distributor of life science research and clinical diagnostic products, today …See details»
GnuBIO - Crunchbase
GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.See details»
Bio-Rad Buys GnuBio; Will Focus on NGS-based Dx for
Apr 15, 2014 GnuBio CEO and Co-founder John Boyce will head up the Cambridge location of Bio-Rad's Digital Biology Center. While the GnuBio technology will continue to be developed …See details»
GnuBIO | Bio-Rad Acquires GnuBIO, Developer of Droplet-Based …
GnuBIO, has developed a DNA sequencing solution that integrates the entire sample preparation workflow on a chip, from sample capture, PCR, and sequencing, to informatics. This capability …See details»
Bio-Rad Shutters Former GnuBio Facility as Part of Digital
Sep 21, 2017 GnuBio had been developing a droplet-based platform for targeted next-generation sequencing, which used a pico-injector technology developed by co-founder David …See details»
Bio-Rad Acquires Sequencing Technology Company GnuBIO
Apr 11, 2014 GnuBIO is a privately-held life sciences company that has developed a droplet-based DNA sequencing technology.See details»
GnuBIO - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
GnuBIO Makes First Sequencing Data Available to Thought …
Apr 6, 2011 GnuBIO, Inc is a private company,www.gnubio.com, and a pioneer in the field of scalable DNA sequencing technology for the Diagnostic and Applied Markets.Utilizing its …See details»
Overview - GnuBIO
The power of the GnuBIO platform resides in the use of proprietary chemistry where the volume of reagents and/or analytes are extremely small. In the GnuBIO system, each droplet works as a …See details»
Bio-Rad Grows Droplet-Based DNA Sequencing Business with …
Apr 11, 2014 Bio-Rad Laboratories said today it acquired GnuBIO, in a deal that expands the acquiring company’s droplet-based DNA sequencing technology offerings within its portfolio of …See details»
Products - GnuBIO
The GnuBIO instrument encompasses all the steps required for DNA sequencing in a single platform including target selection and enrichment, DNA amplification, DNA sequencing and …See details»
News - GnuBIO
GnuBIO Unveils the World’s First Prototype Fully Integrated DNA Sequencer at the Association of Molecular Pathology Conference Cambridge, Massachusetts – (October 24, 2012) – GnuBIO, …See details»